<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30270520</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">2045-7634</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>7</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer medicine</Title>                <ISOAbbreviation>Cancer Med</ISOAbbreviation>            </Journal>            <ArticleTitle>The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.</ArticleTitle>            <Pagination>                <MedlinePgn>5205-5216</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cam4.1786</ELocationID>            <Abstract>                <AbstractText>Nuclear receptor coactivator 1 (NCOA1) plays crucial roles in the regulation of gene expression mediated by a wide spectrum of steroid receptors such as androgen receptor (AR), estrogen receptor α (ER α), and estrogen receptor β (ER β). Therefore, dysregulations of NCOA1 have been found in a variety of cancer types. However, the clinical relevance and the functional roles of NCOA1 in human esophageal squamous cell carcinoma (ESCC) are less known. We found in this study that elevated levels of NCOA1 protein and/or mRNA as well as amplification of the NCOA1 gene occur in human ESCC. Elevated levels of NCOA1 due to these dysregulations were not only associated with more aggressive clinic-pathologic parameters but also poorer survival. Results from multiple cohorts of ESCC patients strongly suggest that the levels of NCOA1 could serve as an independent predictor of overall survival. In addition, silencing NCOA1 in ESCC cells remarkably decreased proliferation, migration, and invasion. These findings not only indicate that NCOA1 plays important roles in human ESCC but the levels of NCOA1 also could serve as a potential prognostic biomarker of ESCC and targeting NCOA1 could be an efficacious strategy in ESCC treatment.</AbstractText>                <CopyrightInformation>© 2018 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Lu</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Immunotherapy and Gastrointestinal Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Weiwei</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Kai</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Guo</LastName>                    <ForeName>Yi</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Endoscopy Centre, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Ditian</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Thoracic Surgery, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yao</LastName>                    <ForeName>Zhimeng</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Immunotherapy and Gastrointestinal Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lin</LastName>                    <ForeName>Xianjie</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Immunotherapy and Gastrointestinal Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Shujun</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Thoracic Surgery, Second Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jiang</LastName>                    <ForeName>Zuojie</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Qing</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, The First People's Hospital of Foshan, Foshan, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jiang</LastName>                    <ForeName>Yi</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Immunotherapy and Gastrointestinal Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Beien</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Science and Education, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Lei</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Immunotherapy and Gastrointestinal Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhou</LastName>                    <ForeName>Fuyou</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Anyang Tumour Hospital, Anyang, Henan, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ren</LastName>                    <ForeName>Hongzheng</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lin</LastName>                    <ForeName>Danxia</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Dianzheng</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yeung</LastName>                    <ForeName>Sai-Ching Jim</ForeName>                    <Initials>SJ</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5170-0822</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Emergency Medicine, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Hao</ForeName>                    <Initials>H</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2860-5912</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Immunotherapy and Gastrointestinal Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Cancer Research Centre, Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Institute of Precision Cancer Medicine and Pathology and Department of Pathology, Jinan University Medical College, Guangzhou, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Tumor Tissue Bank, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <Agency>The Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Li Ka Shing Foundation Grant for Joint Research Program between Shantou University and Technion-Israel Institute of Technology, Shantou University, Guangdong Province</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>The funding for Collaborative and Creative Center, Molecular Diagnosis and Personalized Medicine</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>30973508</GrantID>                    <Agency>National Natural Science Foundation of China</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Li Ka Shing Foundation</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Technion-Israel Institute of Technology</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Shantou University</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Cancer Med</MedlineTA>            <NlmUniqueID>101595310</NlmUniqueID>            <ISSNLinking>2045-7634</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Endocrinol. 2015 Aug;29(8):1170-83</RefSource>                <PMID Version="1">26066330</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2007 Jul 15;13(14):4046-50</RefSource>                <PMID Version="1">17634528</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14745-14750</RefSource>                <PMID Version="1">27930339</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):151-6</RefSource>                <PMID Version="1">19109434</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2010 Feb 15;70(4):1585-94</RefSource>                <PMID Version="1">20145129</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gut. 2015 Mar;64(3):381-7</RefSource>                <PMID Version="1">25320104</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 May 03;8(5):e62986</RefSource>                <PMID Version="1">23671646</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2009 Sep;9(9):615-30</RefSource>                <PMID Version="1">19701241</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Biol Sci. 2012;8(4):470-85</RefSource>                <PMID Version="1">22419892</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2014 May 30;15(6):9718-34</RefSource>                <PMID Version="1">24886814</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2014 Jul 1;74(13):3477-88</RefSource>                <PMID Version="1">24769444</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Med. 2014;65:279-92</RefSource>                <PMID Version="1">24111892</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2011 Jun 28;105(1):118-23</RefSource>                <PMID Version="1">21654685</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Med. 2018 Oct;7(10):5205-5216</RefSource>                <PMID Version="1">30270520</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2005 Sep 1;65(17):7959-67</RefSource>                <PMID Version="1">16140968</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300</RefSource>                <PMID Version="1">20610543</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2004 Oct 1;64(19):7169-77</RefSource>                <PMID Version="1">15466215</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2014 Mar 1;74(5):1506-1517</RefSource>                <PMID Version="1">24390736</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2015 Jul;34(29):3871-80</RefSource>                <PMID Version="1">25284587</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2011 Mar 1;71(5):1742-51</RefSource>                <PMID Version="1">21343398</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2016 Nov 14;16(1):882</RefSource>                <PMID Version="1">27842582</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neoplasia. 2004 Jan-Feb;6(1):1-6</RefSource>                <PMID Version="1">15068665</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1521-7</RefSource>                <PMID Version="1">17446438</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Steroid Biochem Mol Biol. 2013 Nov;138:17-23</RefSource>                <PMID Version="1">23474438</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 1998 Mar;48(1):87-92</RefSource>                <PMID Version="1">9541193</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Physiol. 2016 Feb;231(2):270-4</RefSource>                <PMID Version="1">26201947</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2012 Jan 15;72(2):548-59</RefSource>                <PMID Version="1">22108824</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2012 Feb 28;315(2):138-44</RefSource>                <PMID Version="1">22099875</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocr Relat Cancer. 2005 Jun;12(2):229-44</RefSource>                <PMID Version="1">15947099</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Steroid Biochem Mol Biol. 2006 May;99(2-3):108-14</RefSource>                <PMID Version="1">16616843</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2012 Jan 1;72(1):220-9</RefSource>                <PMID Version="1">22072566</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2009 Jun 15;15(12):4123-30</RefSource>                <PMID Version="1">19470742</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Feb 14;8(7):11896-11905</RefSource>                <PMID Version="1">28060733</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2012 Jun 20;30(18):2265-72</RefSource>                <PMID Version="1">22585694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2006 Nov 1;20(21):2943-8</RefSource>                <PMID Version="1">17050676</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2014 Dec 25;371(26):2499-509</RefSource>                <PMID Version="1">25539106</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2009 Mar 15;15(6):2098-106</RefSource>                <PMID Version="1">19276281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 Sep 15;6(27):23890-904</RefSource>                <PMID Version="1">26287601</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Apr 1;136(7):1636-45</RefSource>                <PMID Version="1">25159681</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Dis. 2014 Feb 27;5:e1088</RefSource>                <PMID Version="1">24577086</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2014 May 1;74(9):2533-44</RefSource>                <PMID Version="1">24648347</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocr Relat Cancer. 2016 Jun;23(6):495-508</RefSource>                <PMID Version="1">27255895</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Biol Sci. 2009;5(3):256-64</RefSource>                <PMID Version="1">19305643</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocr Relat Cancer. 2002 Sep;9(3):155-70</RefSource>                <PMID Version="1">12237244</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2015 Jul 24;290(30):18596-608</RefSource>                <PMID Version="1">26082485</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Gastroenterol Hepatol. 2016 Mar;14(3):338-347.e1</RefSource>                <PMID Version="1">26484704</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Gastroenterol. 2015 Jun 28;21(24):7514-21</RefSource>                <PMID Version="1">26139998</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2015 May 27;16(6):12035-50</RefSource>                <PMID Version="1">26023713</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90</RefSource>                <PMID Version="1">21296855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2015 Aug 10;28(2):240-52</RefSource>                <PMID Version="1">26267537</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2017 Sep 7;67(5):733-743.e4</RefSource>                <PMID Version="1">28844863</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2017 Jan 19;36(3):410-422</RefSource>                <PMID Version="1">27345410</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocrinology. 2003 Apr;144(4):1435-43</RefSource>                <PMID Version="1">12639927</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2013 Nov;4(11):2135-43</RefSource>                <PMID Version="1">24243830</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2013 Aug 19;336(2):325-37</RefSource>                <PMID Version="1">23541682</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2009 May 1;69(9):3819-27</RefSource>                <PMID Version="1">19383905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2016 Nov 15;22(22):5403-5407</RefSource>                <PMID Version="1">27654711</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2017 Mar;241(4):448-462</RefSource>                <PMID Version="1">27801498</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">SRC-1</Keyword>            <Keyword MajorTopicYN="N">coregulator</Keyword>            <Keyword MajorTopicYN="N">esophageal carcinoma</Keyword>            <Keyword MajorTopicYN="N">invasiveness</Keyword>            <Keyword MajorTopicYN="N">migration</Keyword>            <Keyword MajorTopicYN="N">proliferation</Keyword>            <Keyword MajorTopicYN="N">sex steroid receptor signaling</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>08</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>2</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30270520</ArticleId>            <ArticleId IdType="doi">10.1002/cam4.1786</ArticleId>            <ArticleId IdType="pmc">PMC6198200</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>